Holdco Nuvo Group D.G Ltd (NUVOQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Oct 16, 2025, 9:30 AM EDT
Holdco Nuvo Group D.G Revenue
In the year 2023, Holdco Nuvo Group D.G had annual revenue of $176 thousand. Holdco Nuvo Group D.G had revenue of $127 thousand in the half year ending December 31, 2023.
Revenue
176.00K
Revenue Growth
n/a
P/S Ratio
0.02
Revenue / Employee
4.00K
Employees
n/a
Market Cap
3.33K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 176.00K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 1.95M |
| Northwest Biotherapeutics | 1.09M |